Kontron finds a buyer
U.K. ultrasound and patient monitoring firm Kontron Instruments found a buyer last month, only weeks after going into receivership. The company was purchased Feb. 5 by Innermail Ltd., a subsidiary of Charterhouse Group International, a private equity
U.K. ultrasound and patient monitoring firm Kontron Instruments found a buyer last month, only weeks after going into receivership. The company was purchased Feb. 5 by Innermail Ltd., a subsidiary of Charterhouse Group International, a private equity company based in New York City.
At the time it went into receivership, Kontron owed roughly $8 million to its creditors. Its assets were intellectual property rights to its monitoring products, an electronic assembly plant, raw materials, and stock, according to Kontron's receiver, KPMG, an international accounting firm also based in the U.K. (SCAN 2/17/99). Ninety Kontron employees lost jobs as a result of the company's failure, although KPMG anticipates that several of these employees will be hired by Innermail. Charterhouse Group was unavailable for comment on the Kontron purchase.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
